Azi-once Oral Suspension- azithromycin

Composition: Oral Suspension Reconstituted suspension contains 200 mg of azithromycin base per 5ml. Therapeutic Category: Antibiotic, macrolide.


  • Treatment of acute otitis media due to H. influenzae. M. catarrhalis. or S. pneumoniae.
  • Pharyngitis/tonsillitis due to S. pyogenes.
  • Treatment of mild to moderate upper and lower respiratory tract infections.
  • Infections of the skin and skin structure.
  • Community-acquired pneumonia.
  • pharyngitis/tonsillitis (alternative to first-line therapy).
  • genital ulcer disease (chancroid) due to susceptible strains of C. trachomatis. M. catarrhal’s. ff. influenzae. S. aureus. S. pneumoniae, Alycoplasma pneumoniae. and C. psittaci.
  • Acute bacterial exacerbations of chronic obstructive pulmonary disease (COPE)) due to H. influercae. M. catarrhal’s. or S. pneumoniae.
أزى ونس 250 كبسول
أزى ونس 250 كبسول

Unlabeled/Investigational Use

  • Prevention of (or to delay onset of) or treatment of MAC in patients with advanced HIV infection.
  • Prophylaxis of bacterial endocarditis in patients who are allergic to penicillin and undergoing surgical or dental procedures. 


Hypersensitivity to azithromycin, other macrolide antibiotics. or any component of the formulation.


  • Use with caution in patients with hepatic dysfunction; hepatic impairment with or without jaundice has occurred chiefly in older children and adults; it may be accompanied by malaise, nausea, vomiting, abdominal colic. and fever; discontinue use if these occur.
  • May mask or delay symptoms of incubating gonorrhea or syphilis, so appropriate culture and susceptibility tests should be performed prior to initiating azithromycin.
  • Pseudomembranous colitis has been reported with use of macrolide antibiotics.
  • Use with caution with renal dysfunction.
  • Safety and efficacy have not been established in children less than 6 months of age with acute otitis media or community-acquired pneumonia, or in children less than 2 years of age with pharyngitis:tonsillitis. 


Children > 6 months Dosage in Community-acquired pneumonia

10 mg/kg on day 1 (maximum: 500 mg/day) followed by 5 mg/kg/day once daily on days 2 to 5 (maximum: 250 mg/day).

Children > 6 months Dosage in Otitis media

  • 1-day regimen: 30 mg/kg as a single dose (maximum dose: 1500 mg).
  • 3-days regimen: 10 mg/kg once daily for 3 days (maximum: 500 mg/day).
  • 5-days regimen: 10 mg/kg on day 1 (maximum: 500 mg/day) followed by 5 mg/kg/day once daily on days 2 to 5 (maximum: 250 mg/day).

Children > 2 years Dosage in Pharyngitis, tonsillitis

12 mg/kg/day once daily for 5 days (maximum: 500 mg/day) .

Children > 2 years Dosage in Prophylaxis for bacterial endocarditis (unlabeled use)

15 mg/kg 1 hour before the procedure. 

Instructions For Use

  • Shake the bottle containing powder before adding water.
  • Before using the suspension, always shake the bottle well.
  • Discard after 5 days of reconstitution.
أزى -ونس شراب by pharmacia1
أزى -ونس شراب by pharmacia1

Patient Information Leaflet

ENG - Patient Information Leaflet
Azi-once – Patient Information Leaflet
أزى-ونس شراب معلق- النشرة الداخلية

Azi-once: Arabic Information

For Arabic Information
Azi-once: Arabic Information


أضف تعليقك

لن يتم نشر عنوان بريدك الإلكتروني. الحقول الإلزامية مشار إليها بـ *